Cancer Biologics Market - Global Outlook and Forecast 2023-2028

Report ID: 1370676 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Cancer Biologics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cancer Biologics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cancer Biologics Overall Market Size
    2.1 Global Cancer Biologics Market Size: 2021 VS 2028
    2.2 Global Cancer Biologics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cancer Biologics Players in Global Market
    3.2 Top Global Cancer Biologics Companies Ranked by Revenue
    3.3 Global Cancer Biologics Revenue by Companies
    3.4 Top 3 and Top 5 Cancer Biologics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Cancer Biologics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cancer Biologics Players in Global Market
        3.6.1 List of Global Tier 1 Cancer Biologics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cancer Biologics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Cancer Biologics Market Size Markets, 2021 & 2028
        4.1.2 Monoclonal Antibodies
        4.1.3 Vaccines
        4.1.4 Cell and Gene Therapy
        4.1.5 Others
    4.2 By Type - Global Cancer Biologics Revenue & Forecasts
        4.2.1 By Type - Global Cancer Biologics Revenue, 2017-2022
        4.2.2 By Type - Global Cancer Biologics Revenue, 2023-2028
        4.2.3 By Type - Global Cancer Biologics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cancer Biologics Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Cancer Biologics Revenue & Forecasts
        5.2.1 By Application - Global Cancer Biologics Revenue, 2017-2022
        5.2.2 By Application - Global Cancer Biologics Revenue, 2023-2028
        5.2.3 By Application - Global Cancer Biologics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Cancer Biologics Market Size, 2021 & 2028
    6.2 By Region - Global Cancer Biologics Revenue & Forecasts
        6.2.1 By Region - Global Cancer Biologics Revenue, 2017-2022
        6.2.2 By Region - Global Cancer Biologics Revenue, 2023-2028
        6.2.3 By Region - Global Cancer Biologics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Cancer Biologics Revenue, 2017-2028
        6.3.2 US Cancer Biologics Market Size, 2017-2028
        6.3.3 Canada Cancer Biologics Market Size, 2017-2028
        6.3.4 Mexico Cancer Biologics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Cancer Biologics Revenue, 2017-2028
        6.4.2 Germany Cancer Biologics Market Size, 2017-2028
        6.4.3 France Cancer Biologics Market Size, 2017-2028
        6.4.4 U.K. Cancer Biologics Market Size, 2017-2028
        6.4.5 Italy Cancer Biologics Market Size, 2017-2028
        6.4.6 Russia Cancer Biologics Market Size, 2017-2028
        6.4.7 Nordic Countries Cancer Biologics Market Size, 2017-2028
        6.4.8 Benelux Cancer Biologics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Cancer Biologics Revenue, 2017-2028
        6.5.2 China Cancer Biologics Market Size, 2017-2028
        6.5.3 Japan Cancer Biologics Market Size, 2017-2028
        6.5.4 South Korea Cancer Biologics Market Size, 2017-2028
        6.5.5 Southeast Asia Cancer Biologics Market Size, 2017-2028
        6.5.6 India Cancer Biologics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Cancer Biologics Revenue, 2017-2028
        6.6.2 Brazil Cancer Biologics Market Size, 2017-2028
        6.6.3 Argentina Cancer Biologics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cancer Biologics Revenue, 2017-2028
        6.7.2 Turkey Cancer Biologics Market Size, 2017-2028
        6.7.3 Israel Cancer Biologics Market Size, 2017-2028
        6.7.4 Saudi Arabia Cancer Biologics Market Size, 2017-2028
        6.7.5 UAE Cancer Biologics Market Size, 2017-2028
7 Players Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Cancer Biologics Major Product Offerings
        7.1.4 Roche Cancer Biologics Revenue in Global Market (2017-2022)
        7.1.5 Roche Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Cancer Biologics Major Product Offerings
        7.2.4 Novartis Cancer Biologics Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Eli Lilly
        7.3.1 Eli Lilly Corporate Summary
        7.3.2 Eli Lilly Business Overview
        7.3.3 Eli Lilly Cancer Biologics Major Product Offerings
        7.3.4 Eli Lilly Cancer Biologics Revenue in Global Market (2017-2022)
        7.3.5 Eli Lilly Key News
    7.4 Sanofi
        7.4.1 Sanofi Corporate Summary
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Cancer Biologics Major Product Offerings
        7.4.4 Sanofi Cancer Biologics Revenue in Global Market (2017-2022)
        7.4.5 Sanofi Key News
    7.5 Celgene
        7.5.1 Celgene Corporate Summary
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Cancer Biologics Major Product Offerings
        7.5.4 Celgene Cancer Biologics Revenue in Global Market (2017-2022)
        7.5.5 Celgene Key News
    7.6 Pfizer
        7.6.1 Pfizer Corporate Summary
        7.6.2 Pfizer Business Overview
        7.6.3 Pfizer Cancer Biologics Major Product Offerings
        7.6.4 Pfizer Cancer Biologics Revenue in Global Market (2017-2022)
        7.6.5 Pfizer Key News
    7.7 Bayer
        7.7.1 Bayer Corporate Summary
        7.7.2 Bayer Business Overview
        7.7.3 Bayer Cancer Biologics Major Product Offerings
        7.7.4 Bayer Cancer Biologics Revenue in Global Market (2017-2022)
        7.7.5 Bayer Key News
    7.8 Johnson & Johnson
        7.8.1 Johnson & Johnson Corporate Summary
        7.8.2 Johnson & Johnson Business Overview
        7.8.3 Johnson & Johnson Cancer Biologics Major Product Offerings
        7.8.4 Johnson & Johnson Cancer Biologics Revenue in Global Market (2017-2022)
        7.8.5 Johnson & Johnson Key News
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Corporate Summary
        7.9.2 Bristol-Myers Squibb Business Overview
        7.9.3 Bristol-Myers Squibb Cancer Biologics Major Product Offerings
        7.9.4 Bristol-Myers Squibb Cancer Biologics Revenue in Global Market (2017-2022)
        7.9.5 Bristol-Myers Squibb Key News
    7.10 Merck
        7.10.1 Merck Corporate Summary
        7.10.2 Merck Business Overview
        7.10.3 Merck Cancer Biologics Major Product Offerings
        7.10.4 Merck Cancer Biologics Revenue in Global Market (2017-2022)
        7.10.5 Merck Key News
    7.11 Amgen
        7.11.1 Amgen Corporate Summary
        7.11.2 Amgen Business Overview
        7.11.3 Amgen Cancer Biologics Major Product Offerings
        7.11.4 Amgen Cancer Biologics Revenue in Global Market (2017-2022)
        7.11.5 Amgen Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Biologics Market Opportunities & Trends in Global Market
    Table 2. Cancer Biologics Market Drivers in Global Market
    Table 3. Cancer Biologics Market Restraints in Global Market
    Table 4. Key Players of Cancer Biologics in Global Market
    Table 5. Top Cancer Biologics Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cancer Biologics Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cancer Biologics Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cancer Biologics Product Type
    Table 9. List of Global Tier 1 Cancer Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cancer Biologics Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cancer Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cancer Biologics Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cancer Biologics Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cancer Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cancer Biologics Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cancer Biologics Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cancer Biologics Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cancer Biologics Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cancer Biologics Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cancer Biologics Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cancer Biologics Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cancer Biologics Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cancer Biologics Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cancer Biologics Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cancer Biologics Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cancer Biologics Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cancer Biologics Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cancer Biologics Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cancer Biologics Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Cancer Biologics Product Offerings
    Table 32. Roche Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Cancer Biologics Product Offerings
    Table 35. Novartis Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 36. Eli Lilly Corporate Summary
    Table 37. Eli Lilly Cancer Biologics Product Offerings
    Table 38. Eli Lilly Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 39. Sanofi Corporate Summary
    Table 40. Sanofi Cancer Biologics Product Offerings
    Table 41. Sanofi Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 42. Celgene Corporate Summary
    Table 43. Celgene Cancer Biologics Product Offerings
    Table 44. Celgene Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 45. Pfizer Corporate Summary
    Table 46. Pfizer Cancer Biologics Product Offerings
    Table 47. Pfizer Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 48. Bayer Corporate Summary
    Table 49. Bayer Cancer Biologics Product Offerings
    Table 50. Bayer Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 51. Johnson & Johnson Corporate Summary
    Table 52. Johnson & Johnson Cancer Biologics Product Offerings
    Table 53. Johnson & Johnson Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 54. Bristol-Myers Squibb Corporate Summary
    Table 55. Bristol-Myers Squibb Cancer Biologics Product Offerings
    Table 56. Bristol-Myers Squibb Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 57. Merck Corporate Summary
    Table 58. Merck Cancer Biologics Product Offerings
    Table 59. Merck Cancer Biologics Revenue (US$, Mn), (2017-2022)
    Table 60. Amgen Corporate Summary
    Table 61. Amgen Cancer Biologics Product Offerings
    Table 62. Amgen Cancer Biologics Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cancer Biologics Segment by Type in 2021
    Figure 2. Cancer Biologics Segment by Application in 2021
    Figure 3. Global Cancer Biologics Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cancer Biologics Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cancer Biologics Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cancer Biologics Revenue in 2021
    Figure 8. By Type - Global Cancer Biologics Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cancer Biologics Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cancer Biologics Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cancer Biologics Revenue Market Share, 2017-2028
    Figure 12. US Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cancer Biologics Revenue Market Share, 2017-2028
    Figure 16. Germany Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cancer Biologics Revenue Market Share, 2017-2028
    Figure 24. China Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cancer Biologics Revenue Market Share, 2017-2028
    Figure 30. Brazil Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cancer Biologics Revenue Market Share, 2017-2028
    Figure 33. Turkey Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cancer Biologics Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Eli Lilly Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sanofi Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celgene Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Pfizer Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Bayer Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Johnson & Johnson Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bristol-Myers Squibb Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Merck Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Amgen Cancer Biologics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Cancer Biologics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Biologics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Biologics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports